Figs. 5From: Anti-atherosclerotic effects of naringenin and quercetin from Folium Artemisiae argyi by attenuating Interleukin-1 beta (IL-1β)/ matrix metalloproteinase 9 (MMP9): network pharmacology-based analysis and validationMolecular docking results of the main compounds and protein targets. (A-C) represent quercetin interacted action mode with MMP9 (A), IL-1β (B), VEGFA (C)Back to article page